{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:03:31Z","timestamp":1787508211244,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81001444"],"award-info":[{"award-number":["81001444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81202043"],"award-info":[{"award-number":["81202043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science & Technology Development Project of Nanjing, China","award":["201201055"],"award-info":[{"award-number":["201201055"]}]},{"name":"Science & Technology Development Project of Nanjing, China","award":["2012YX001"],"award-info":[{"award-number":["2012YX001"]}]}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2014.01.047","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T21:15:47Z","timestamp":1391462147000},"page":"730-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer"],"prefix":"10.1016","volume":"132","author":[{"given":"Qingmin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.01.047_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0015","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","article-title":"Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications","volume":"18","author":"Kirschmann","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0020","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","article-title":"Tumor cell vasculogenic mimicry: from controversy to therapeutic promise","volume":"181","author":"Seftor","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1756-9966-28-124","article-title":"Effect of genistein on vasculogenic mimicry formation by human uveal melanoma cells","volume":"28","author":"Cong","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/1471-2407-12-535","article-title":"Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry","volume":"12","author":"Wu","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4161\/cbt.19602","article-title":"Vasculogenic mimicry is a marker of poor prognosis in prostate cancer","volume":"13","author":"Liu","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/IGC.0b013e31828c166d","article-title":"Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient","volume":"23","author":"Chung","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2174\/18715206113139990006","article-title":"Oncogenic MicroRNA-27a is a target for genistein in ovarian cancer cells","volume":"13","author":"Xu","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0060","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0065","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/onc.2011.269","article-title":"Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2","volume":"31","author":"Chao","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0070","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/carcin\/bgs161","article-title":"MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer","volume":"33","author":"Aydogdu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0002-9440(10)63899-0","article-title":"Differential regulation of EphA2 in normal and malignant cells","volume":"162","author":"Walker-Daniels","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-1-2","article-title":"Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis","volume":"1","author":"Cheng","year":"2002","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0085","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1096\/fj.05-4038fje","article-title":"Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression","volume":"19","author":"Brantley-Sieders","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","article-title":"EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown","volume":"168","author":"Ojima","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/14728222.9.6.1179","article-title":"EphA2 as a target for ovarian cancer therapy","volume":"9","author":"Landen","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0100","doi-asserted-by":"crossref","first-page":"e57160","DOI":"10.1371\/journal.pone.0057160","article-title":"Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma","volume":"8","author":"Itzhaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0105","first-page":"693","article-title":"Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma","volume":"16","author":"Sun","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1525-1438.2007.01034.x","article-title":"Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo","volume":"18","author":"Su","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-011-0578-5","article-title":"Clinical significance of vasculogenic mimicry in human gliomas","volume":"105","author":"Liu","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0120","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1007\/DCR.0b013e3181beb4ff","article-title":"Prognostic role of vasculogenic mimicry in colorectal cancer","volume":"52","author":"Baeten","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0125","first-page":"585","article-title":"Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma","volume":"38","author":"Gao","year":"2009","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0130","doi-asserted-by":"crossref","first-page":"e57188","DOI":"10.1371\/journal.pone.0057188","article-title":"Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by glioma stem-like cells","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2011.03.026","article-title":"MicroRNA-200a inhibits CD133\/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2","volume":"122","author":"Wu","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","article-title":"A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer","volume":"114","author":"Hu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0195","doi-asserted-by":"crossref","first-page":"40725","DOI":"10.1074\/jbc.M111.275495","article-title":"miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells","volume":"286","author":"Eades","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3892\/or.2013.2267","article-title":"Downregulated microRNA-200a promotes EMT and tumor growth through the wnt\/beta-catenin pathway by targeting the E-cadherin repressors ZEB1\/ZEB2 in gastric adenocarcinoma","volume":"29","author":"Cong","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0155","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-12-1959","article-title":"MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer","volume":"19","author":"Yu","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/cbt.5.2.2510","article-title":"VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry","volume":"5","author":"Hess","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0165","doi-asserted-by":"crossref","first-page":"e16264","DOI":"10.1371\/journal.pone.0016264","article-title":"Role of microRNA-26b in glioma development and its mediated regulation on EphA2","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0170","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4161\/cbt.7.7.6168","article-title":"EphA2 overexpression promotes ovarian cancer growth","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.22415","article-title":"EphA2 overexpression is associated with angiogenesis in ovarian cancer","volume":"109","author":"Lin","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0180","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-03-0589","article-title":"EphA2 expression is associated with aggressive features in ovarian carcinoma","volume":"10","author":"Thaker","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0185","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4161\/cbt.5.10.3225","article-title":"Analysis of EphA2 expression and mutant p53 in ovarian carcinoma","volume":"5","author":"Merritt","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ygyno.2014.01.047_bb0190","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/cbt.10.12.13582","article-title":"Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer","volume":"10","author":"Merritt","year":"2010","journal-title":"Cancer Biol Ther"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T04:34:41Z","timestamp":1565152481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814001073"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.047","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}